Cardiovascular Diabetology

Title Publication Date Language Citations
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–20172018/06/08English1,092
Association between insulin resistance and the development of cardiovascular disease2018/08/31English955
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice2005/04/29English552
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease2006/01/13English468
Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies2018/08/31English360
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart2019/02/02English334
Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance2014/10/20English329
Diabetes, cardiovascular disease and the microcirculation2018/04/18English286
Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes2017/09/29English282
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice2014/10/26English266
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study2017/10/23English260
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin2021/08/23English238
The effect of dapagliflozin treatment on epicardial adipose tissue volume2018/01/04English231
Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis2019/07/30English190
Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes2016/03/24English187
Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes2011/02/25English184
Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes2017/01/13English183
Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes2015/08/07English180
Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations2022/05/06English168
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats2019/11/28English168
Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study2016/05/03English167
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons2005/09/16English167
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice2018/04/27English162
Association between triglyceride glucose index and arterial stiffness in Korean adults2018/03/21English162
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study2017/07/06English161
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin2021/07/23English159
Protein kinase RNA- like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)- mediated endoplasmic reticulum stress- induced apoptosis in diabetic cardiomyopathy2013/11/02English158
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus2013/01/02English156
Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome2020/06/13English155
Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study2017/03/01English154